Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2022-04-04 | John R. Sylvester was appointed as a director of the Company in July 2019. He is currently serving as CEO of Curium Pharma’s SPECT and International businesses. |
| 2023-05-01 | John R. Sylvester was appointed as a director of the Company in July 2019. He has served as Non-Executive Chairman of the Board of Directors of the Company since February 2023. The current members of the Compensation Committee are Mr. Sylvester (Chair), Dr. Stoll, and Dr. Aharon. The current members of the Nominating Committee are Mr. Salamon (Chair), Dr. Stoll and Mr. Sylvester. The following table sets forth the compensation awarded to, earned by or paid to each non-employee director who served on our Board in 2022. John Sylvester Fees Earned or Paid in Cash ($) 47,000 Option Awards($) 54,121 Total ($) 101,121. |
| 2024-04-12 | John R. Sylvester was appointed as a director of the Company in July 2019. He has served as the Non-Executive Chairman of the Board since February 2023. ... The current members of the Compensation Committee are Mr. Sylvester (Chair), Dr. Stoll, and Dr. Aharon, each of whom is “independent” within the meaning of the Nasdaq listing rules. ... The current members of the Nominating Committee are Mr. Salamon (Chair), Dr. Stoll and Mr. Sylvester, each of whom is “independent,” within the meaning of the Nasdaq listing rules. ... The following table sets forth the compensation awarded to, earned by or paid to each non-employee director who served on our Board in 2023. ... John Sylvester 79,927 124,956 204,883 |
| 2025-04-01 | John R. Sylvester was appointed as a director of the Company in July 2019. He has served as the Non-Executive Chairman of the Board since February 2023. The current members of the Compensation Committee are Mr. Sylvester (Chair) and Dr. Aharon, each of whom is “independent” within the meaning of the Nasdaq listing rules. The current members of the Nominating Committee are Mr. Salamon (Chair), Dr. Martell and Mr. Sylvester, each of whom is “independent,” within the meaning of the Nasdaq listing rules. |
Data sourced from SEC filings. Last updated: 2025-12-06